MEET THE TEAM
Concordia Integrated Solutions, LLC is a team of highly respected and experienced experts from the pharmaceutical and consumer healthcare industries. We offer creative and strategic solutions to complex challenges along with tactical execution support.
FOUNDING MEMBER
David Grob, MS, RAC
A seasoned Regulatory Affairs leader with over 25 years extensive experience in the consumer healthcare industry. His broad expertise includes OTC monograph policy interpretation
and product support, regulatory strategy for Rx-to-OTC switch projects, OTC monograph / DSHEA labeling and advertising review, claim development, risk assessments, compliance challenges, NAD/FTC issues and resolution, and FDA negotiations and representations at FDA meetings. His contribution to the successful launch of over 450 consumer healthcare products is part of his proud legacy and a demonstration of his ability to navigate complex regulatory landscapes and drive regulatory strategies for novel products while being a strong business enabler. David holds an M.S. in Biology from Adelphi University and a B.S. in Biotechnology from the Rochester Institute of Technology.
“It's not just about navigating regulations—it's about driving business success through informed and creative regulatory strategies.”
AREAS OF EXPERTISE
CHC Regulatory Affairs
Regulatory Policy Interpretation
Strategy Development
Creative Problem Resolution
Business Acumen
Collaboration
Compliance
Risk Mitigation
AREAS OF EXPERTISE
Scientific Leadership
Strategic Innovation
Creative Problem Resolution
Business Acumen
FDA Audits
Collaboration
Compliance
Risk Mitigation
FOUNDING MEMBER
Annelies Verbeek, MD
Annelies Verbeek is a highly respected medical executive with broad experience and expertise in medical affairs, clinical development, women’s healthcare, and general medicine.
Throughout her career at Sanofi, Boehringer Ingelheim Pharmaceuticals and Organon, she has successfully navigated the pharmaceutical, consumer healthcare, Rx-to-OTC switches, and self-care world. Annelies holds a Doctor of Medicine degree from the University of Utrecht, the Netherlands, and a Diploma in Pharmaceutical Medicine from the Royal College of Physicians, UK.
“I believe in the power of science, exploration, and storytelling to change the world.”
FOUNDING MEMBER
Jan Summers, PhD
Jan Summers is a highly respected toxicologist with extensive clinical research, strategic management and leadership experience. Her strong scientific expertise was developed by leading preclinical and clinical programs during Phase I pharmaceutical drug development programs, identifying new surgical applications and clinical programs for medical devices, and conducting the toxicology safety assessments for cosmetic products. Her strong interpersonal and business skills ensure
customer focus is maintained, and results are quality driven and
solution oriented. Jan is a postdoctoral fellow in pharmacology
and toxicology at the University of Arizona, Tucson.
Jan holds a Ph.D. in pharmacology and toxicology from
university of Arizona, and an M.S. in medical biology and B.S. in
chemistry and marine chemistry from Long Island University.
"Success in clinical research lies not just in innovation, but in the seamless integration of science, strategy, and collaboration".
AREAS OF EXPERTISE
Scientific Leadership
Strategic Innovation
Creative Problem Resolution
Cosmetic and OTC Product Safety
Clinical Research
FDA Audits
Compliance Excellence
Risk Mitigation
AREAS OF EXPERTISE
Corporate Strategy
Innovation
OTC Business/Product/Clinical Development
MEMBER
Donald K. Riker, PhD
Don is recognized for his broad experience and creativity helping science-based consumer businesses use consumer insight and technology to grow revenues and create new opportunities.
He spent 20 years in Personal Healthcare at Procter & Gamble and five years at Chattem Inc. where he became Vice President of Research & Development and Chief Scientific Officer. His responsibilities included product development, quality assurance, regulatory affairs, analytical, safety and consumer affairs.
Don is a former Editor-in-Chief, OTC Product and member of the American Academy of Allergy, Asthma & Immunology, American Society of Pharmacology & Experimental Therapeutics, American Society of Clinical Pharmacology & Therapeutics, Infectious Disease Society of America, and The Society for Neuroscience. He has a Ph.D. in Neurobiology from Cornell University, and completed his post-doctoral training in medical research at Yale University.
“Innovative growth in consumer healthcare lies at the intersection of scientific rigor and consumer insight.”
MEMBER
Sue James, RAC (US/Global), FRAPS
Sue James is a globally recognized leader in regulatory affairs with a distinguished career in Consumer Healthcare spanning several decades. After earning her B.A. in Chemistry and Biochemistry from the University of York, she began her career with GSK Consumer Health, where she gained hands-on experience in product development before transitioning to regulatory affairs. Sue has held progressively senior roles, culminating in her appointment as Worldwide Head of Regulatory for GSK Consumer Health in 2000.
Under her leadership, she built a top-tier regulatory organization, successfully guiding multiple Rx-to-OTC switches, including Tagamet and Voltaren, and overseeing the integration of major acquisitions like Block Drug, Novartis Consumer, and Pfizer Consumer Health. An active participant in key industry associations, Sue has also served on the Board of the Regulatory Affairs Professional Society.
After leaving Haleon in 2024, she continues to champion opportunities that empower self-care with trusted, high-quality products, now also as part of the Concordia Consortium.
“My mission is to navigate global regulations with rigor, transforming challenges into opportunities that empower consumers and elevate the industry.”
AREAS OF EXPERTISE
Global Regulatory Affairs
Rx-to-OTC Switching
Compliance
Strategic Integration
Collaboration
Advocacy
Organizational Development
Creative Problem Solving
Risk Identification